Skip to main content
. 2020 May 18;14:829–838. doi: 10.2147/PPA.S221897

Table 2.

Comparison of Predicted versus Stated Preferences

Predicted Treatment Preference Stated Preference Total
Triple Therapy Methotrexate Monotherapy
Triple therapy 18* 6 24
Methotrexate monotherapy 2 3* 5
Total 20 9 29

Note: *Predicted treatment agreed with stated preference for 21/29 (72%) of patients.